PharmaShots | Incisive News in 3 Shots

Subscribe Now

lumicell

Lumicell’s imaging platform gains US FDA Approval to Detect Residual Breast Cancer

Lumicell’s imaging platform gains US FDA Approval to Detect Residual Breast Cancer

April 18, 2024

Lumicell Reports the Submission of Premarket Approval Application to the US FDA for Lumicell Direct Visualization System

Lumicell Reports the Submission of Premarket Approval Application to the US FDA for Lumicell Direct Visualization System

April 19, 2023

Lumicell Reports the NDA Submission of Lumisight Optical Imaging Agent to the US FDA for the Detection and Removal of Intraoperative Breast Cancer

Lumicell Reports the NDA Submission of Lumisight Optical Imaging Agent to the US FDA for the Detection and Removal of Intraoperati...

March 22, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us